Invention Grant
![Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease](/docs/US/2019-02-19/US10208061B2/abs.jpg.600x600.jpg)
- Patent Title: Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
-
Application No.: US15729910Application Date: 2017-10-11
-
Publication No.: US10208061B2Publication Date: 2019-02-19
- Inventor: Thomas D. Aicher , Peter L. Toogood , Xiao Hu
- Applicant: Lycera Corporation
- Applicant Address: US MI Ann Arbor
- Assignee: Lycera Corporation
- Current Assignee: Lycera Corporation
- Current Assignee Address: US MI Ann Arbor
- Agency: Dechert LLP
- Main IPC: C07D498/04
- IPC: C07D498/04 ; C07D471/04 ; C07D491/052
![Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease](/abs-image/US/2019/02/19/US10208061B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides tetrahydro[1,8]naphthyridine and related compounds, pharmaceutical compositions, methods of promoting ROR activity, increasing the amount of IL-17 in a subject, and treating cancer using such tetrahydro[1,8]naphthyridine and related compounds.
Public/Granted literature
Information query
